Barclays’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Barclays’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-77,427	Closed	-$435K	–	5490
2022 Q3	$435K	Sell	77,427 -25,589	-25%	-$160K	﹤0.01%	2785
2022 Q2	$446K	Sell	103,016 -1,805	-2%	-$10.3K	﹤0.01%	2950
2022 Q1	$1.22M	Buy	+104,821	New	+$1.25M	﹤0.01%	2246

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Barclays's OYST Position: Q4 2022 in Review

Barclays sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 77,427 shares — an estimated $435K sold.

Barclays first reported a position in OYST in Q1 2022 and held it in 3 quarters. The position peaked at $1.22M in Q1 2022. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

Barclays reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Barclays sold 77,427 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $435K.
Barclays first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Barclays's Oyster Point Pharma, Inc. Common Stock position peaked at $1.22M in Q1 2022.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.